Nike beat the quarter but torched the year, a guidance reset rather than a miss. It sees fiscal 2027 adjusted EPS of $1.15-1.35, a $1.25 midpoint versus $1.69 expected, and revenue declining by a high-single-digit percentage. Inventories fell, but the guide is horrendous. x.com  x.com  x.com  x.com 

Nike could be re-rated lower as an apparel company with falling revenue and EPS that is struggling to show CEO Elliott Hill's turnaround is taking root after two years. Q1 revenue missed at $11.21B, FY27 revenue is guided down by a high-single-digit percentage versus a 2% expected decline, and adjusted EPS guidance of $1.15-$1.35 sits well below the $1.65 consensus, with weakness in China, sportswear and Jordan. Its 26.4x 2027 P/E is low only versus its ~30x history. x.com  x.com 

Nike's brand concerns look priced in; stabilization, not sudden revenue acceleration, is what the speculative long needs. A few good campaigns and a return to large stores could help, though China consumers will be a drag. Short-term EPS is a poor indicator, and customers may return after trying other brands. x.com  x.com 

Nike's latest report confirms a structural unwinding, not a temporary dip, despite the EPS beat. The $0.48 versus $0.44 beat came from expense cuts, a lower tax rate and a lowered bar, while revenue missed and management warned of a high-single-digit full-year sales decline. NIKE Direct fell 8%, digital 13% and owned stores 5%, Greater China plunged 22%, and consumers are fleeing to On, Hoka and Adidas. Cost cuts can't restore cultural heat, and earnings power looks halved. x.com 

Nike is a stagnant company losing pricing power, pointing to more tough years for shareholders. Revenue fell 4% last quarter, the only line still shrinking while gross margin expanded, inventory fell 3% and North America grew 2%, per the quoted post. x.com 

Nike's valuation pays investors to wait for a turnaround that will take longer than expected. It trades at just 16x earnings, near its lowest valuation ever, with a roughly 5% dividend yield, and would need a 127% rally to regain its 200-week moving average. Revenue is projected to fall another 4% in FY2027, but the business will grow again; the market prices it as if it were disappearing. Unlike Novo Nordisk, Nike faces no patent cliff. x.com  x.com 

Nike's guidance for a high-single-digit revenue decline in fiscal 2027 is all investors need to know. x.com 

Nike's situation is worse than expected. x.com 

Nike is the best stock to buy when others are fearful. x.com 

Nike's turnaround is looking much longer than bulls expected, and about 17x forward earnings is not cheap for a business growing low single digits. China sales fell 26% FX-neutral while Adidas' Greater China sales grew 15%, pointing to a Nike problem, not a China problem. Sportswear fell low double digits with Dunk revenue down about 50%, Jordan fell mid-teens, and most PACE savings are expected only in FY29-30; Performance grew high single digits. The must-buy price is $25. x.com  x.com  x.com